FDA Inspection
Angelini Pharma, Inc.Angelini Pharma, Inc. – FDA Inspection, Mar 17, 2015
Record Details
This FDA Inspection record concerns Angelini Pharma, Inc., with an inspection on March 17, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Angelini Pharma, Inc.
- Inspection Date
- March 17, 2015
- Product Type
- Drugs
View Company Profile
ID · b3940b75-c31b-4396-bbd6-323c79e33985
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 920215
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Angelini Pharma, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 2, 2016 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| April 22, 2014 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| August 19, 2011 | VAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Angelini Pharma, Inc.
- FDA Inspection 989300 - 2016-09-02
- FDA Inspection 875272 - 2014-04-22
- FDA Inspection 740481 - 2011-08-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.